4.7 News Item

NICE guidance on cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen

Journal

LANCET ONCOLOGY
Volume 13, Issue 6, Pages 573-574

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1470-2045(12)70220-6

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available